Bank Of America Corp Lyra Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 21,352 shares of LYRA stock, worth $1,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,352

Previous 52,664 59.46%

Holding current value

$1,921

Previous $11,000 81.82%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.13 - $0.22 $4,070 - $6,888	-31,312 Reduced 59.46%	21,352 $2,000
Q4 2024 Feb 14, 2025	BUY	$0.17 - $0.28 $584 - $962	3,436 Added 6.98%	52,664 $11,000
Q3 2024 Nov 14, 2024	SELL	$0.24 - $0.34 $8,935 - $12,658	-37,231 Reduced 43.06%	49,228 $12,000
Q2 2024 Aug 14, 2024	SELL	$0.26 - $6.25 $19,015 - $457,112	-73,138 Reduced 45.83%	86,459 $24,000
Q1 2024 May 15, 2024	BUY	$4.55 - $6.53 $67,881 - $97,421	14,919 Added 10.31%	159,597 $992,000
Q4 2023 Feb 14, 2024	BUY	$2.82 - $5.24 $89,856 - $166,967	31,864 Added 28.24%	144,678 $758,000
Q2 2023 Aug 14, 2023	BUY	$1.98 - $4.33 $15,931 - $34,839	8,046 Added 7.68%	112,814 $463,000
Q1 2023 May 12, 2023	BUY	$1.95 - $3.09 $5,877 - $9,313	3,014 Added 2.96%	104,768 $210,000
Q4 2022 Feb 10, 2023	BUY	$2.44 - $5.42 $17,382 - $38,612	7,124 Added 7.53%	101,754 $319,000
Q3 2022 Nov 14, 2022	SELL	$4.95 - $6.6 $14,300 - $19,067	-2,889 Reduced 2.96%	94,630 $474,000
Q2 2022 Aug 12, 2022	BUY	$4.12 - $7.51 $63,114 - $115,045	15,319 Added 18.64%	97,519 $550,000
Q1 2022 May 16, 2022	SELL	$3.5 - $5.36 $5,740 - $8,790	-1,640 Reduced 1.96%	82,200 $330,000
Q4 2021 Feb 08, 2022	SELL	$4.22 - $9.41 $112,551 - $250,974	-26,671 Reduced 24.13%	83,840 $366,000
Q3 2021 Nov 15, 2021	BUY	$6.06 - $9.43 $481,915 - $749,911	79,524 Added 256.64%	110,511 $1.01 Million
Q2 2021 Sep 13, 2021	BUY	$6.91 - $12.59 $214,120 - $390,126	30,987 New	30,987 $249,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

25M

Call Options Held

56.6K

Put Options Held

33.9K

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $2.86M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Lyra Therapeutics, Inc. Transaction History